,
Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases, Aliment Pharmacol Ther, vol.45, pp.37-49, 2009. ,
The global burden of IBD: from 2015 to 2025, Nat Rev Gastroenterol Hepatol, vol.12, pp.720-727, 2015. ,
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012, Eur J Cancer Oxf Engl, vol.49, pp.1374-403, 1990. ,
Definition of supportive care: does the semantic matter?, Curr Opin Oncol, vol.26, pp.372-381, 2014. ,
The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults, J Infect Dis, vol.192, pp.377-86, 2005. ,
Impact of vaccination on invasive pneumococcal disease in adults with focus on the immunosuppressed, J Infect, vol.71, pp.422-429, 2015. ,
Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine, vol.29, pp.3398-412, 2011. ,
Zalmanovici Trestioreanu A. Influenza vaccines in immunosuppressed adults with cancer. Cochrane Database Syst Rev, vol.008983, 2013. ,
Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009-13, Lancet Respir Med, vol.3, pp.709-727, 2015. ,
Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis, J Autoimmun, vol.80, pp.10-27, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01909042
Influenza vaccination for immunocompromised patients: summary of a systematic review and meta-analysis. Influenza Other Respir Viruses, vol.7, pp.72-77, 2013. ,
Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae, Med Oncol Northwood Lond Engl, vol.19, pp.71-79, 2002. ,
Influenza vaccination perception and coverage among patients with malignant disease, Vaccine, vol.33, pp.1682-1689, 2015. ,
A quality improvement project significantly increased the vaccination rate for immunosuppressed patients with IBD, Inflamm Bowel Dis, vol.19, pp.1809-1823, 2013. ,
Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement, Inflamm Bowel Dis, vol.20, pp.246-50, 2014. ,
Factors associated with influenza vaccination among adult cancer patients: a case-control study, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.20, pp.899-905, 2014. ,
Influenza vaccination coverage in patients treated with chemotherapy: current clinical practice, Neth J Med, vol.71, pp.472-479, 2013. ,
Vaccination in Inflammatory Bowel Disease Patients: Attitudes, Knowledge, and Uptake, J Crohns Colitis, vol.9, pp.439-483, 2015. ,
Vaccine counseling: a content analysis of patient-physician discussions regarding human papilloma virus vaccine, Vaccine, vol.29, pp.7343-7352, 2011. ,
Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics, Gastroenterology, vol.124, pp.1767-73, 2003. ,
Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study, Scand J Gastroenterol, vol.35, pp.1075-81, 2000. ,
Genetics versus environment in inflammatory bowel disease: results of a British twin study, BMJ, vol.312, pp.95-101, 1996. ,
Prevalence of inflammatory bowel disease among relatives of patients with Crohn's disease, Scand J Gastroenterol, vol.26, pp.302-308, 1991. ,
Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect, J Crohns Colitis, vol.8, pp.717-742, 2014. ,
Appendectomy and protection against ulcerative colitis, N Engl J Med, vol.344, pp.808-822, 2001. ,
The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review, Aliment Pharmacol Ther, vol.16, pp.51-60, 2002. ,
Epidemiology and natural history of inflammatory bowel diseases, Gastroenterology, vol.140, pp.1785-94, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00631553
Long-term evolution of disease behavior of Crohn's disease, Inflamm Bowel Dis, vol.8, pp.244-50, 2002. ,
Crohn's disease. The Lancet, vol.389, pp.1741-55, 2017. ,
Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey, J Crohns Colitis, vol.1, pp.10-20, 2007. ,
Nutritional deficiencies in inflammatory bowel disease: therapeutic approaches, Clin Nutr Edinb Scotl, vol.32, pp.904-914, 2013. ,
Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc, vol.10, pp.639-684, 2012. ,
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012, Eur J Cancer Oxf Engl, vol.49, pp.1374-403, 19902013-04. ,
Survie des personnes atteintes de cancer en France, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02087526
Focus on an unusual rise in pancreatic cancer incidence in France, Int J Epidemiol, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-01541663
Risk Factors for Pancreatic Adenocarcinoma and Prospects for Screening, Gastroenterol Hepatol, vol.6, pp.246-54, 2010. ,
Explaining gastric cancer survival differences among European countries, Int J Cancer, vol.109, pp.737-778, 2004. ,
Epidemiology of esophageal cancer, World J Gastroenterol WJG, vol.19, pp.5598-606, 2013. ,
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management, J Crohns Colitis, vol.11, pp.769-84, 2017. ,
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management, J Crohns Colitis, vol.11, pp.3-25, 2017. ,
Update on Tofacitinib for Inflammatory Bowel Disease, Gastroenterol Hepatol, vol.12, pp.572-576, 2016. ,
Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis, N Engl J Med, vol.367, pp.616-640, 2012. ,
Treat to target: a proposed new paradigm for the management of Crohn's disease, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc, vol.13, pp.1042-1050, 2015. ,
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target, Am J Gastroenterol, vol.110, pp.1324-1362, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01191653
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial, Lancet Lond Engl, 2017. ,
Algorithmes de prise en charge de la rectocolite hémorragique en 2015 : Consensus National Français. Hépato-Gastro Oncol Dig, vol.23, pp.32-42, 2016. ,
Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease, J Crohns Colitis, vol.10, pp.989-97, 2016. ,
Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis, Gastroenterology, vol.146, pp.85-95, 2014. ,
Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis, Gastroenterology, vol.146, pp.96-109, 2014. ,
Anti-TNF therapy in inflammatory bowel diseases: a huge review, Minerva Gastroenterol Dietol, vol.56, pp.233-276, 2010. ,
Ustekinumab induction and maintenance therapy in refractory Crohn's disease, N Engl J Med, vol.367, pp.1519-1547, 2012. ,
Infliximab, azathioprine, or combination therapy for Crohn's disease, N Engl J Med, vol.362, pp.1383-95, 2010. ,
Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis, Gastroenterology, vol.146, pp.392-400, 2014. ,
Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections, Aliment Pharmacol Ther, vol.30, pp.253-64, 2009. ,
Association between tumour necrosis factor-? inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study, BMJ, vol.350, p.2809, 2015. ,
Crohn's Disease Activity and Concomitant Immunosuppressants Affect the Risk of Serious and Opportunistic Infections in Patients Treated With Adalimumab, Am J Gastroenterol, vol.111, pp.1806-1821, 2016. ,
Diabetes and risk of infections with immunomodulator therapy in inflammatory bowel diseases, Aliment Pharmacol Ther, vol.41, pp.1141-1149, 2015. ,
Cancers complicating inflammatory bowel disease, N Engl J Med, vol.372, pp.1441-52, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-01301711
Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease, Gastroenterology, vol.141, pp.1621-1628, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00631539
Immunization in the adult immunocompromised host, Autoimmun Rev, vol.11, pp.212-220, 2012. ,
Pathways for self-tolerance and the treatment of autoimmune diseases, Lancet Lond Engl, vol.357, pp.2115-2136, 2001. ,
The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults, J Infect Dis, vol.192, pp.377-86, 2005. ,
The burden of influenza complications in different high-risk groups: a targeted literature review, J Med Econ, vol.16, pp.264-77, 2013. ,
Coordinating preventive medicine in patients with inflammatory bowel disease: whose responsibility is it anyway?, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc, vol.7, pp.500-501, 2009. ,
Vaccination and screening for infections in patients with inflammatory bowel disease: a survey of Australian gastroenterologists, Intern Med J, vol.41, pp.462-469, 2011. ,
Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge, Inflamm Bowel Dis, vol.17, pp.2536-2576, 2011. ,
Insufficient knowledge of korean gastroenterologists regarding the vaccination of patients with inflammatory bowel disease, Gut Liver, vol.8, pp.242-249, 2014. ,
Influenza vaccination in adult patients with solid tumours treated with chemotherapy, Eur J Cancer Oxf Engl, vol.76, pp.134-177, 19902017-05. ,
Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses, Am J Gastroenterol, vol.101, pp.1834-1874, 2006. ,
Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease, Gut, vol.60, pp.930-936, 2011. ,
Perception about influenza and pneumococcal vaccines and vaccination coverage among patients with malignancies and their family members, J BUON Off J Balk Union Oncol, vol.18, pp.511-516, 2013. ,
Vaccination in Inflammatory Bowel Disease Patients: Attitudes, Knowledge, and Uptake, J Crohns Colitis, vol.9, pp.439-483, 2015. ,
Vaccination in Inflammatory Bowel Disease Patients: Attitudes, Knowledge, and Uptake, J Crohns Colitis, vol.9, pp.439-483, 2015. ,
Health maintenance in the inflammatory bowel disease patient, Gastroenterol Clin North Am, vol.41, pp.325-362, 2012. ,
Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge, Inflamm Bowel Dis, vol.17, pp.2536-2576, 2011. ,
Are primary care providers uncomfortable providing routine preventive care for inflammatory bowel disease patients?, Dig Dis Sci, vol.56, pp.819-843, 2011. ,
Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification, Inflamm. Bowel Dis, 2011. ,